These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2413481)

  • 1. Hydroxyurea and hemoglobin F in patients with myeloproliferative syndromes.
    Alter BP; Gilbert HS
    Prog Clin Biol Res; 1985; 191():455-61. PubMed ID: 2413481
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.
    Nathan DG
    Prog Clin Biol Res; 1985; 191():475-500. PubMed ID: 2413483
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM; Pace B
    Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacology of hydroxyurea].
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1995; 26(1):39-45. PubMed ID: 7747561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromes.
    Alter BP; Gilbert HS
    Blood; 1985 Aug; 66(2):373-9. PubMed ID: 2410068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietic development and hemoglobin switching in human embryos: cellular and molecular aspects.
    Peschle C; Mavilio F; Migliaccio G; Migliaccio AR; Russo G; Mastroberardino G; Marinucci M
    Prog Clin Biol Res; 1985; 191():383-96. PubMed ID: 2413477
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases].
    Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P
    Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.
    Nienhuis AW; Ley TJ; Humphries RK; Young NS; Dover G
    Ann N Y Acad Sci; 1985; 445():198-211. PubMed ID: 2409872
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hydroxyurea on foetal haemoglobin in myeloproliferative & myelodysplastic syndromes.
    Advani SH; Venugopal P; Charak BS; Das Gupta A; Mazumdar AT; Gopal R; Nair CN; Saikia TK; Nadkarni KS; Kurkure PA
    Indian J Med Res; 1990 Apr; 92():83-5. PubMed ID: 1695200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea treatment of myeloproliferative disorders. Macro-megaloblastic blood and bone marrow changes.
    Löfvenberg E; Nilsson T; Wahlin A; Jacobsson L
    Acta Med Scand; 1987; 222(2):169-74. PubMed ID: 3673669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    Prog Clin Biol Res; 1989; 316B():281-93. PubMed ID: 2482498
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ; Charache S; Boyer SH
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
    Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
    Ann Hematol; 2004 Jul; 83(7):430-3. PubMed ID: 14722738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of hemoglobin synthesis by S-phase specific drugs in the K562 cell line.
    Dean A; Wu YJ; Ley T; Fordis CM; Schechter AN
    Prog Clin Biol Res; 1985; 191():205-16. PubMed ID: 2413473
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential regulation of A gamma and G gamma fetal hemoglobin mRNA levels by hydroxyurea and butyrate.
    Xu J; Zimmer DB
    Exp Hematol; 1998 Mar; 26(3):265-72. PubMed ID: 9502623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
    Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
    Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction.
    Pace BS; Zein S
    Dev Dyn; 2006 Jul; 235(7):1727-37. PubMed ID: 16607652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome.
    Hennemann B; Bross KJ; Reichle A; Andreesen R
    Ann Hematol; 1993 Sep; 67(3):133-4. PubMed ID: 8373900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.